August 3, 2021

AARDA and 50+ Patient Groups Send Letter to Key Members of Congress on Drug Pricing Priorities for Autoimmune Patients

Media Contact:  Katie Baumer [email protected] 202-800-5364 AARDA and 50+ Patient Groups Send Letter to Key Members of Congress on Drug Pricing Priorities for Autoimmune Patients Washington, […]
July 13, 2021

Gail Devers, Three-Time Olympic Gold Medalist, thanks AARDA for helping raise awareness of Graves’ disease

Gail Devers, Three-Time Olympic Gold Medalist, thanks AARDA for helping raise awareness of Graves’ disease and TED during Graves’ Disease Awareness Month     This Graves Disease […]
June 1, 2021

Top Researchers Identify Areas for Autoimmune Disease Research at AARDA-Hosted Colloquium

Top Researchers Identify Areas for Autoimmune Disease Research at AARDA-Hosted Colloquium On Saturday, May 1st, 2021, the American Autoimmune Related Disease Association (AARDA) hosted the 15th […]
April 29, 2021

The Courage of Princess Gracie

The Courage of Princess Gracie  In many ways, Gracie Reed, 16, a student at Bel Air High School in Bel Air, Maryland, is like any other […]
April 16, 2021

Non-Medical Switching: A Threat to Patient Health and Wellness

Non-Medical Switching: A Threat to Patient Health and Wellness By Lilly Stairs, Founder of Patient Authentic and Interim CEO, AARDA Non-medical switching is a dangerous practice […]
March 4, 2021

“Coronavirus Aid, Relief, and Economic Security Act” (CARES) Act

“Coronavirus Aid, Relief, and Economic Security Act” (CARES) Act As the production for COVID-19 vaccinations increases due to multiple FDA approved vaccines on the market, it […]
January 29, 2021

AARDA Statement on HHS Decision to Delay Implementation of Rebate Rule

AARDA Statement on HHS Decision to Delay Implementation of Rebate Rule Washington, D.C. (January 29, 2021) — Brett McReynolds, Vice President of Programs and Public Policy […]
January 13, 2021

AARDA Announces Leadership Transition

AARDA Announces Leadership Transition Board Appoints Interim CEO and Initiates Formal Executive Search Process As Randall Rutta Joins National Health Council Washington, D.C. (January 13, 2021) […]
December 22, 2020

AARDA Statement on CMS Decision to Delay Copay Assistance Rule

AARDA Statement on CMS Decision to Delay Copay Assistance Rule Washington, D.C. (Tuesday, December 22, 2020) — Autoimmune patients welcome the Administration’s decision to delay implementation […]
December 17, 2020

AARDA Signs on to ACCC Letter on NBPP 2022

AARDA Signs on to ACCC Letter on NBPP 2022 AARDA signed on to the All Copays Count Coalition’s Sign-On Letter regarding the HHS Notice of Benefit […]
December 2, 2020

AARDA Joins CV19 Educate America Campaign

AARDA Joins CV19 Educate America Campaign AARDA has joined the national CV19 Educate America Campaign to help inform the public about CV19 CheckUp, an online system […]
November 24, 2020

AARDA Most Favored Nation Model (MFN) Statement of Concern

AARDA Most Favored Nation Model (MFN) Statement of Concern The American Autoimmune Related Diseases Association (AARDA) is greatly concerned that the Most Favored Nation Model (MFN) […]
November 24, 2020

INSIGHT: Tim Walbert, CEO of Horizon Therapeutics

INSIGHT: Tim Walbert, CEO of Horizon Therapeutics   Our series, INSIGHT: Conversations with Thought Leaders, has a new interview with the CEO of Horizon Therapeutics. On […]
November 18, 2020

Thyroid Eye Disease (TED) Awareness Week

September 3, 2020

Innovation in Pain Management: 5 Takeaways from a Survey of Chronic Pain Patients

AARDA received 450 individual responses to the Patient Experiences with Chronic Pain Survey this June. The findings illustrate the key needs of patients in pain and […]